Association of TLR5 gene polymorphisms in ulcerative colitis patients of North India and their role in cytokine homeostasis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Meena, Naresh Kumar ^a   Ahuja, Vineet ^b   Meena, Kusumlata ^c   Paul, Jaishree ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c SMS MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; INTERLEUKIN 6; TLR5 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN HOMEOSTASIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TLR4 GENE; TLR5 GENE; ULCERATIVE COLITIS; AGED; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CHILD; DEMOGRAPHY; GENE FREQUENCY; GENE LOCUS; GENETICS; GENOTYPE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD; COLITIS, ULCERATIVE; CYTOKINES; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENOTYPE; HUMANS; INDIA; INTERFERON-GAMMA; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84925655302     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120697     Document Type: Article

References (30)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417-429. PMID: 12167685
2. Kaser A, Sebastian Z, Richard SB. Inflammatory bowel disease. Annu Rev Immunol. 2010; 28:573-62. doi: 10.1146/annurev-immunol-030409-101225 PMID: 20192811
3. Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006; 41:10-16. PMID: 16501852
4. Beutler B, Hoebe K, Du X, Ulewitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. Journal of Leukocyte Biology. 2003; 74: 479-485. PMID: 12960260
5. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Richard A, et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303: 1522-1526. PMID: 15001781
6. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005; 17: 1-14. PMID: 15585605
7. Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology. 2008; 125:145-153. doi: 10.1111/j.1365-2567.2008.02939.x PMID: 18798918
8. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires 'disease. J Exp Med. 2003; 198: 1563-1572. PMID: 14623910
9. Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH, et al. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2006; 290: 1157-1163.
10. Pierik M, Joossens S, Steen KV, Schuerbeek NV, Vlietinck R, Rutgeerts P, et al. Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis. 2006; 12: 1-8. PMID: 16374251
11. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000; 68: 7010-701. PMID: 11083826
12. Trejo-de la OA, Torres J, Pérez-Rodríguez M, Camorlinga-Ponce M, Luna FL, Lezcano E, et al. TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori associated gastroduodenal diseases. Clin Immunol. 2008; 129: 333-340. doi: 10.1016/j.clim.2008.07.009 PMID: 18755634
13. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus and implications. Gut. 2006; 55: 749-753. PMID: 16698746
14. Szkaradkiewicz A, Marciniak R, Chudzicka-Strugała I, Wasilewska A, Drews M, Mejewski P, et al. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Arch. Immunol. Ther. Exp. 2009; 57: 291-294. doi: 10.1007/s00005-009-0031-z PMID: 19578817
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16:1215. PMID: 3344216
16. Meena NK, Ravi Verma, Nirmal Verma, Ahuja V, Paul J. TLR4 D299G polymorphism modulates cytokine expression in Ulcerative Colitis. Journal of clinical Gastroenterolgy. 2013; 47: 773-80. doi: 10.1097/MCG.0b013e31828a6e93 PMID: 23470644
17. Hawn TR, Scholes D, Li SS, Wang H, Yang Y, Roberts PL, et al. Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women. PLoS ONE. 2009; 4(6): e5990. doi:10. 1371/journal.pone.0005990 PMID: 19543401
18. Haerynck F, Mahachie John JM, Van Steen K, Schelstraete P, Van daele S, Loeys B, et al. Genetic variations in toll-like receptor pathway and lung function decline in Cystic Fibrosis patients. Human Immunology. 2013; 74: 1649-1655. doi: 10.1016/j.humimm.2013.08.282 PMID: 23994582
19. Kao YL, French RA, Williams G. Polymorphism report: identification of two common single nucleotide polymorphisms in the human toll-like receptor 5 (TLR5) genes. Molecular and Cellular Probes. 2004; 18: 205. PMID: 15135456
20. Klimosch SN, Forsti A, Eckert J, Knezevic J, Bevier M, von SchonfelsW, et al. Functional TLR5 Genetic Variants Affect Human Colorectal Cancer Survival. Cancer Res. 2013; 73:7232-7242. doi: 10.1158/0008-5472.CAN-13-1746 PMID: 24154872
21. Beckmann B, Heine H, Weissmuller KH, Jung G, Brock R, Akira S, et al. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunology. 2005; 35: 282-289. PMID: 15580661
22. Takeuchi O, Kawal T, Mohlradt P F, Morr M, Radolf JD, Zychlinsky A, et al. Discrimination of bacterial lipoprotein by toll like recprors 6. International immunology. 2001; 13:933-940. PMID: 11431423
23. Kim EJ, Chung WC, Lee KM, Paik CN, Jung SH, Lee BI, et al. Association between Toll-Like Receptors/ CD14 Gene Polymorphisms and Inflammatory Bowel Disease in Korean Population. J Korean Med Sci. 2012; 27: 72-77. doi: 10.3346/jkms.2012.27.1.72 PMID: 22219617
24. Chen L, Lin MJ, Zhan LL, LV PX. Analysis of TLR4 and TLR2 polymorphisms in inflammatory bowel disease in a Guangxi Zhuang population. World J Gastroenterol. 2012; 14: 6856-6860.
25. Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, Govender T, et al. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens. 2005; 66: 125-130. PMID: 16029432
26. Ueta M, Tokunaga K, Sotozono C, Sawai H, Tamiya G, Kinoshita S, et al. HLA-A∗0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications. PLoS ONE. 2012; 7(8):e43650. doi:10.1371/journal.pone.0043650 PMID: 22912896
27. Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, et al. Association between polymorphisms in the toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J. Gastroenterol. 2005; 11: 681-685. PMID: 15655821
28. Yang ZH, Dai Q, Gu YJ, Guo QX, Gong L. Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma. Cancer Sci. 2012; 103: 653-658. doi: 10.1111/j.1349-7006.2012.02210.x PMID: 22320262
29. Yang XQ, Murani SE, Ponsuksili S, Wimmers PK. Association of TLR4 polymorphism with cytokine expression level and pulmonary lesion score in pigs. Mol Biol Rep. 2012; 39:7003-7009. doi: 10.1007/ s11033-012-1530-2 PMID: 22307794
30. Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006; 101:1012-1023. PMID: 16696785